Kimberly Gentile, SVP, Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 47,000 shares at $76.42 ($3.6M) on 2020-10-08, disclosed to the SEC on 2020-10-09.
Open-market sale of $3.6M BHVN by SVP, Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.62 | 5,261 | $398K | 11.1% |
| 2 | $75.62 | 5,261 | $398K | 11.1% |
| 3 | $76.42 | 15,781 | $1.2M | 33.6% |
| 4 | $76.42 | 15,781 | $1.2M | 33.6% |
| 5 | $77.42 | 2,458 | $190K | 5.3% |
| 6 | $77.42 | 2,458 |
| $190K |
| 5.3% |
| Total | $76.35 avg | 47,000 | $3.6M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |
| BHVN | SELL | 2018-06-19 | $1.0M | — | Filing → |